Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study.

Author: HambergerB, LjunggrenJ G, LundellG, TallstedtL, TaubeA, TörringO, WallinG

Paper Details 
Original Abstract of the Article :
The patients' views and costs of three different forms of treatment for Graves' hyperthyroidism were investigated. The study comprises 174 patients with Graves' hyperthyroidism who were stratified into two age groups: 20 to 34 years and 35 to 55 years. The younger group was randomly assigned to trea...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1089/thy.1998.8.653

データ提供:米国国立医学図書館(NLM)

Quality of Life Aspects and Costs in Treatment of Graves' Hyperthyroidism with Antithyroid Drugs, Surgery, or Radioiodine: Results from a Prospective, Randomized Study

This study investigates the patients' perspectives and costs associated with three different treatment options for Graves' hyperthyroidism: antithyroid drugs, surgery, and radioiodine. The researchers aimed to identify any differences in patient satisfaction and cost-effectiveness among these treatment approaches.

The study, which involved 174 patients with Graves' hyperthyroidism, found no significant differences in patient satisfaction among the three treatment groups. The researchers also evaluated the costs of each treatment option over a two-year period. They found that the cost proportion between medical and surgical treatment was significantly different before and after including relapse costs. The cost proportion between medical, surgical, and radioiodine treatment was also different before and after including relapse costs.

Navigating the Treatment of Graves' Hyperthyroidism: Balancing Cost and Patient Preferences

This study provides valuable insights into the complexities of treating Graves' hyperthyroidism, highlighting the need to consider both patient preferences and cost-effectiveness. The researchers' findings suggest that all three treatment options are effective and well-tolerated, but the cost-effectiveness of each option may vary depending on factors such as relapse rates and treatment duration.

Understanding Graves' Hyperthyroidism

Graves' hyperthyroidism is a condition caused by an overactive thyroid gland. This study explores the quality of life aspects and costs associated with different treatment options for this condition. The study's findings can help patients and healthcare providers make informed decisions about the best treatment approach.

Dr.Camel's Conclusion

This study underscores the importance of a multifaceted approach to treating Graves' hyperthyroidism, taking into account patient preferences, cost-effectiveness, and the potential for long-term complications. The researchers' findings provide valuable information for guiding treatment decisions and ensuring the best possible outcomes for patients with this condition.

Date :
  1. Date Completed 1998-11-06
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

9737359

DOI: Digital Object Identifier

10.1089/thy.1998.8.653

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.